drugset
drugset / Trial / NCT02871908

Lactobacillus Reuteri DSM 17938 in the Prevention of Antibiotic-associated Diarrhea in Children: Protocol of a Randomized Controlled Trial

NCT02871908 ↗

Phase 4 Completed 250 enrolled Medical University of Warsaw
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The aim of this study is to assess the effect of Lactobacillus reuteri DSM 17938 administration for the prevention of diarrhea and AAD in children.

Timeline

Start
2016-12
Primary completion
2018-03
Completion
2018-03

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Lactobacillus reuteri DSM 17938 Other / unclassified 2e+08 cells Oral

Indications

diarrheal disease